HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Burning mouth syndrome: a discussion of a complex pathology.

Abstract
Burning mouth syndrome is a complex pathology for which there is very little information about the etiology and pathogenesis. This lack of knowledge leaves patients with suboptimal treatments. This article discusses the existing scientific evidence about this disease. Since topical oral use of clonazepam have been shown to be effective and safe to treat some patients suffering with burning mouth syndrome, formulations including clonazepam are included with this article. Compounding topical preparations of clonazepam offers opportunities for compounding pharmacists to be more involved in improving the quality of life of burning mouth syndrome patients.
AuthorsEyal Zur
JournalInternational journal of pharmaceutical compounding (Int J Pharm Compd) 2012 May-Jun Vol. 16 Issue 3 Pg. 196-205 ISSN: 1092-4221 [Print] United States
PMID23050296 (Publication Type: Journal Article, Review)
Chemical References
  • Paroxetine
  • Clonazepam
  • Thioctic Acid
Topics
  • Acupuncture Therapy
  • Burning Mouth Syndrome (diagnosis, epidemiology, etiology, therapy)
  • Clonazepam (therapeutic use)
  • Humans
  • Paroxetine (therapeutic use)
  • Prevalence
  • Thioctic Acid (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: